Sean Smith SEC EDGAR Filings (CIK 0001914769)

SEC EDGAR filings, ownership reports, and insider transactions for Sean Smith.

Business address
C/O Neoleukin Therapeutics, Inc., 188 E. Blaine Street, Suite 450, Seattle, WA, 98102
Top holdings (ownership)
NLTX
Get insider transactions for this reporting owner
Sean Smith has filed 7 SEC EDGAR filings since 03 Mar 2022

Latest Filings

Recent SEC filings for Sean Smith including 144, 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
144 Open 144 document View SEC filing for 144 04 Mar 2024
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 14 Aug 2023 10 Aug 2023 001-36327
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Feb 2023 01 Feb 2023 001-36327
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 12 Aug 2022 10 Aug 2022 001-36327
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 04 Aug 2022 02 Aug 2022 001-36327
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Mar 2022 02 Mar 2022 001-36327
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Mar 2022 02 Mar 2022 001-36327

About this filer

Sean Smith files with the SEC under CIK 0001914769. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages